NuNaf Tablets

Minipee Nasal Spray (For the management of Poly Urea & Poly Dipsia) Back

NuNaf Tablets Each ml contains : Desmopressin Acetate USP 0.1 mg, Equivalent to Desmopressin 89 mcg, Purified water upto 1 ml, Benzalkonium Chloride 0.1 mg, Excipients q.s.

Indications:
• Central Diabetes Insipidus: Desmopressin is the treatment of choice forcentral diabetes insipidus a condition where the kidneys are unable to conserve water.
• Primary Nocturnal Enuresis: Used to treat bedwetting (Enuresis) in children and adults.
• Hemophilia A:Treats mild to moderate hemophilia A, a bleeding disorder.
• Von Willebrand Disease:Helps in certain type of Von Willebrand disease, a bleeding disorder.

Description:

  • Targeted Relief for Nocturia and Urinary Incontinence.
  • Enhanced and sustained antidiuretic effect: Reduced nighttime urine production, prolonging uninterrupted sleep.
  • Minimal stimulation of uterine muscles and vasoconstriction: Lower risk of adverse effects such as convulsion and hyponatremia.
  • Improves initial sleep period: supports better sleep architecture and quality of life.

Dosage:

The dossing of desmopressin can vary depending on the condition being treated and the patient’s individual response.

  • Diabetes Insipidus: The usual dose for central diabetes insipidus in adults is 0.1 to 0.4 mg daily, given intranasally.
  • Bleeding Disorder (Hemophilia A, Von Willebrand Disease): the dose for preventing bleeding varies depending on the condition and individual response.

© Copyright 2025. NuLife Pharmaceuticals. All Rights Reserved.